Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking-Reference-Cited by-同舟云学术

Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking

Published:2015-01-01 Issue:1 Volume:2 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Pelton Stephen I.¹²,Shea Kimberly M.¹,Weycker Derek³,Farkouh Raymond A.⁴,Strutton David R.⁴,Edelsberg John³

Affiliation:

1. Boston University Schools of Medicine and Public Health

2. Boston Medical Center

3. Policy Analysis Inc., Brookline, Massachusetts

4. Pfizer Inc., Collegeville, Pennsylvania

Abstract

Abstract Using data from 3 private healthcare claims repositories, we evaluated the incidence of pneumococcal disease among adults with US Advisory Committee on Immunization Practices (ACIP) defined at-risk conditions or rheumatoid arthritis, lupus, Crohn's disease, and neuromuscular disorder/seizures and those with traditional high-risk conditions. We observed that adults with ≥2 concurrent comorbid conditions had pneumococcal disease incidence rates that were as high as or higher than rates observed in those with traditional high-risk conditions.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/2/1/ofv020/33620962/ofv020.pdf

Reference13 articles.

1. Rates of pneumococcal disease in adults with chronic medical conditions;Shea;Open Forum Infect Dis,2014

2. Use of 13-Valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2012

3. Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine;Pelton;Clin Infect Dis,2014

4. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia;Sherwin;J Infect Dis,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rates of Lower Respiratory Tract Illness in US Adults by Age and Comorbidity Profile;Infectious Diseases and Therapy;2024-01

2. Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study;Pneumonia;2023-10-05

3. Risk of Pneumococcal Disease in US Adults by Age and Risk Profile;Open Forum Infectious Diseases;2023-04-12

4. Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23;Journal of Medical Economics;2022-12-02

5. Pneumococcal Disease in High-Risk Adults in Lebanon: Expert Opinion;Vaccines;2022-10-01